CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
CTSA 临床试验基础设施
基本信息
- 批准号:8365200
- 负责人:
- 金额:$ 287.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-06-01 至 2012-06-26
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject represents an estimate of the percentage of the CTSA funding that is
being utilized for a broad area of research (AIDS research, pediatric research, or
clinical trials). The Total Cost listed is only an estimate of the amount of CTSA
infrastructure going towards this area of research, not direct funding provided by
the NCRR grant to the subproject or subproject staff.
We propose to develop the Institute of Translational Health Sciences (ITHS) to support the increasingly nterdisciplinary and collaborative nature of translational research in our environment. The ITHS will significantly enhance the ongoing collaboration between three major research institutions in our region-the University of Washington (UW), Fred Hutchinson Cancer Research Center (FHCRC), and Children's Hospital and Regional Medical Center (CHRMC). Furthermore, the ITHS will strengthen translational research ties with Group Health Cooperative, the Benaroya Research Institute, and existing clinical and research infrastructure developed through the UW across the 5 state WWAMI region. Finally, the ITHS will gnite scientific collaboration with the community as a full translational research partner creating solid pathways of communication and research based interactions. Through the ITHS, we will bring together the rich pool of translational research resources in our region within a common infrastructure that synergizes with institutional infrastructures. The ITHS will function as a "collaboratory"; a structure that spans all institutions to foster collaboration, career development, education, and the translational research process itself. The ITHS will be structured to achieve the following overarching goals: (1) Enhance and further develop collaboration networks within.our environment and into the community, (2) Provide the educational programs and career development needed to strengthen translational research at all levels, (3) Support innovative research, research infrastructure and the integration of innovative technologies into translational research, and, (4) Foster a community that values translational research as a priority in our environment. The ITHS will adapt resources to meet the members evolving research needs. To achieve such flexibility we will use an evaluation strategy that is dynamic and emphasizes a systems based approach, where the evaluation'process is continuous with frequent assessment of resources and activity followed by an adjustment of short term goals so that more rapid impact can be made in long term outcomes. The result is a continuous process improvement that wil maximize the ITHS' ability to support and facilitate innovative translational research within and across partner institutions and the community.
该子项目代表了 CTSA 资金百分比的估计
被用于广泛的研究领域(艾滋病研究、儿科研究或
临床试验)。 列出的总成本只是 CTSA 金额的估计值
该研究领域的基础设施,而不是直接资助
NCRR 向子项目或子项目人员提供的补助金。
我们建议建立转化健康科学研究所(ITHS),以支持我们环境中日益增强的跨学科和协作性质的转化研究。 ITHS 将显着加强我们地区三个主要研究机构——华盛顿大学 (UW)、弗雷德·哈钦森癌症研究中心 (FHCRC) 以及儿童医院和地区医疗中心 (CHRMC) 之间正在进行的合作。此外,ITHS 将加强与 Group Health Cooperative、贝纳罗亚研究所以及通过威斯康星大学在 WWAMI 地区 5 个州开发的现有临床和研究基础设施的转化研究联系。最后,ITHS 将作为全面转化研究合作伙伴与社区开展科学合作,创建坚实的沟通和基于研究的互动途径。通过 ITHS,我们将把本地区丰富的转化研究资源汇集到一个与机构基础设施协同的共同基础设施中。 ITHS 将发挥“合作机构”的作用;一个跨越所有机构的结构,以促进合作、职业发展、教育和转化研究过程本身。 ITHS 的构建将实现以下总体目标:(1) 加强并进一步发展我们的环境内和社区内的协作网络,(2) 提供加强各级转化研究所需的教育计划和职业发展,(3) 支持创新研究、研究基础设施以及将创新技术整合到转化研究中,(4) 培育一个将转化研究视为我们环境中优先事项的社区。 ITHS 将调整资源以满足成员不断变化的研究需求。为了实现这种灵活性,我们将使用动态的评估策略,强调基于系统的方法,其中评估过程是连续的,经常评估资源和活动,然后调整短期目标,以便对长期结果产生更快速的影响。其结果是持续的流程改进,将最大限度地提高 ITHS 支持和促进合作机构和社区内部和跨合作机构和社区的创新转化研究的能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mary L. Disis其他文献
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop
- DOI:
10.1186/s40425-019-0640-y - 发表时间:
2019-07-04 - 期刊:
- 影响因子:10.600
- 作者:
Davide Bedognetti;Michele Ceccarelli;Lorenzo Galluzzi;Rongze Lu;Karolina Palucka;Josue Samayoa;Stefani Spranger;Sarah Warren;Kwok-Kin Wong;Elad Ziv;Diego Chowell;Lisa M. Coussens;Daniel D. De Carvalho;David G. DeNardo;Jérôme Galon;Howard L. Kaufman;Tomas Kirchhoff;Michael T. Lotze;Jason J. Luke;Andy J. Minn;Katerina Politi;Leonard D. Shultz;Richard Simon;Vésteinn Thórsson;Joanne B. Weidhaas;Maria Libera Ascierto;Paolo Antonio Ascierto;James M. Barnes;Valentin Barsan;Praveen K. Bommareddy;Adrian Bot;Sarah E. Church;Gennaro Ciliberto;Andrea De Maria;Dobrin Draganov;Winson S. Ho;Heather M. McGee;Anne Monette;Joseph F. Murphy;Paola Nisticò;Wungki Park;Maulik Patel;Michael Quigley;Laszlo Radvanyi;Harry Raftopoulos;Nils-Petter Rudqvist;Alexandra Snyder;Randy F. Sweis;Sara Valpione;Roberta Zappasodi;Lisa H. Butterfield;Mary L. Disis;Bernard A. Fox;Alessandra Cesano;Francesco M. Marincola - 通讯作者:
Francesco M. Marincola
Immunologic biomarkers as correlates of clinical response to cancer immunotherapy
- DOI:
10.1007/s00262-010-0960-8 - 发表时间:
2011-01-08 - 期刊:
- 影响因子:5.100
- 作者:
Mary L. Disis - 通讯作者:
Mary L. Disis
Tumor stromal barriers to the success of adoptive T cell therapy
- DOI:
10.1007/s00262-007-0356-6 - 发表时间:
2007-07-24 - 期刊:
- 影响因子:5.100
- 作者:
Vy Phan;Mary L. Disis - 通讯作者:
Mary L. Disis
Vaccines for breast cancer prevention: Are we there yet?
预防乳腺癌的疫苗:我们还在吗?
- DOI:
10.1016/j.mam.2024.101292 - 发表时间:
2024-08-01 - 期刊:
- 影响因子:10.300
- 作者:
Shaveta Vinayak;Denise L. Cecil;Mary L. Disis - 通讯作者:
Mary L. Disis
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art
- DOI:
10.1186/s40425-018-0453-4 - 发表时间:
2018-12-01 - 期刊:
- 影响因子:10.600
- 作者:
Lisa H. Butterfield;Mary L. Disis;Bernard A. Fox;David R. Kaufman;Samir N. Khleif;Ena Wang - 通讯作者:
Ena Wang
Mary L. Disis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mary L. Disis', 18)}}的其他基金
Developing Community-Responsive mHealth and AI/ML: Understanding Perspectives of Hispanic Community Members in Washington State
开发社区响应型移动医疗和人工智能/机器学习:了解华盛顿州西班牙裔社区成员的观点
- 批准号:
10598360 - 财政年份:2022
- 资助金额:
$ 287.98万 - 项目类别:
CTSA INFRASTRUCTURE FOR PEDIATRIC CLINICAL TRIALS
用于儿科临床试验的 CTSA 基础设施
- 批准号:
8365201 - 财政年份:2011
- 资助金额:
$ 287.98万 - 项目类别:
Vaccinating against IGFBP-2 to prevent ovarian cancer relapse
接种 IGFBP-2 疫苗可预防卵巢癌复发
- 批准号:
8322539 - 财政年份:2011
- 资助金额:
$ 287.98万 - 项目类别:
相似海外基金
Support for Institutes and Research Groups on Qualitative and Multi-Method Research: 2024-2026
对定性和多方法研究机构和研究小组的支持:2024-2026
- 批准号:
2343087 - 财政年份:2024
- 资助金额:
$ 287.98万 - 项目类别:
Standard Grant
Collaborative Research: Conference: Mathematical Sciences Institutes Diversity Initiative
合作研究:会议:数学科学研究所多样性倡议
- 批准号:
2317573 - 财政年份:2024
- 资助金额:
$ 287.98万 - 项目类别:
Continuing Grant
Collaborative Research: Conference: Mathematical Sciences Institutes Diversity Initiative
合作研究:会议:数学科学研究所多样性倡议
- 批准号:
2317570 - 财政年份:2024
- 资助金额:
$ 287.98万 - 项目类别:
Continuing Grant
Collaborative Research: Conference: Mathematical Sciences Institutes Diversity Initiative
合作研究:会议:数学科学研究所多样性倡议
- 批准号:
2317572 - 财政年份:2024
- 资助金额:
$ 287.98万 - 项目类别:
Continuing Grant
Collaborative Research: Conference: Mathematical Sciences Institutes Diversity Initiative
合作研究:会议:数学科学研究所多样性倡议
- 批准号:
2317569 - 财政年份:2024
- 资助金额:
$ 287.98万 - 项目类别:
Continuing Grant
Collaborative Research: Conference: Mathematical Sciences Institutes Diversity Initiative
合作研究:会议:数学科学研究所多样性倡议
- 批准号:
2317571 - 财政年份:2024
- 资助金额:
$ 287.98万 - 项目类别:
Standard Grant
NATIONAL INSTITUTES OF HEALTH (NIH), INTRAMURAL RESEARCH PROGRAM (IRP), GENE THERAPY TASK FORCE (GTTF), CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMOS), SPECIALIZED SUPPORT SERVICESS4 AX
美国国立卫生研究院 (NIH)、校内研究计划 (IRP)、基因治疗工作组 (GTTF)、合同开发和制造组织 (CDMOS)、专业支持服务4 AX
- 批准号:
10950093 - 财政年份:2023
- 资助金额:
$ 287.98万 - 项目类别:
Statement of Interest for the 2024 Canadian Institutes of Health Research (CIHR) Institute of Aging Summer Program in Aging; Proposed Career Path; Research Proposal
2024 年加拿大健康研究所 (CIHR) 老龄化研究所夏季项目的兴趣声明;
- 批准号:
497847 - 财政年份:2023
- 资助金额:
$ 287.98万 - 项目类别:
AI Institutes Virtual Organization (AIVO): Expanding the Network
人工智能研究所虚拟组织 (AIVO):扩展网络
- 批准号:
2332864 - 财政年份:2023
- 资助金额:
$ 287.98万 - 项目类别:
Standard Grant
SBIR Phase I: A novel method to scaling mentoring and career development in Institutes of Higher Education
SBIR 第一阶段:一种扩大高等教育机构指导和职业发展的新方法
- 批准号:
2232502 - 财政年份:2023
- 资助金额:
$ 287.98万 - 项目类别:
Standard Grant














{{item.name}}会员




